4.8 Article

Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment

期刊

WATER RESEARCH
卷 39, 期 19, 页码 4790-4796

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.watres.2005.09.018

关键词

pharmaceuticals; musks; sewage; coagulation-flocculation; flotation; adsorption; fat; temperature

向作者/读者索取更多资源

Two physico-chemical processes, coagulation-flocculation and flotation, have been assessed for enhancing the removal of some selected pharmaceutical and personal care products (PPCPs) present in sewage, Eight compounds, representative of three main groups of PPCPs according to their physico-chemical properties, have been selected: lipophilic compounds (the synthetic musks Galaxolide and Tonalide), neutral compounds (the tranquillizer Diazepam and the antiepileptic Carbamazepine) and acidic compounds (the anti-inflammatories Ibuprofen, Naproxen and Diclofenae). During the coagulation-flocculation assays, the main parameters considered were the selection of the additives, their doses and the temperature of operation (12 or 25 degrees C), Musks which are highly lipophilic and Diclofenae-with significant sorption affinity-were removed around 50 70%. at both temperatures independently of the dose and type of coagulant used, However, the rest or the compounds, which are more hydrophilic, were affected to a lesser degree (with maximum reductions below 25%). The exceptions to this behavior were Carbamazepine and Ibuprofen, which were not removed under any condition tested. During the flotation assays. the parameters studied were the initial content of fat in wastewaters and temperature. Again, musks were removed to a greater degree (35-60%), followed by Diazepam (40-50%) and Diclofenae (20 45%) and, to a lesser extent, Carbamazepine (20-35%), Ibuprofen (10-25%) and Naproxen (10-30%). The best results were always, obtained at 25 degrees C, although in some cases the operation at 12 degrees C gave similar results, The removal Of musks and neutral compounds was higher in wastewaters with a high fat content (around 150 mgl(-1)). (c) 2005 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据